Trials / Completed
CompletedNCT00997256
Study to Investigate Effects of a Herbal Drug Compared to Placebo on Sleep
Phase I, Placebo-controlled, Double-blind, Randomised, Single-centre Study of Single Cross-over Design to Investigate the Effects of the Herbal Preparation Neurapas® Balance Compared With Placebo on Sleep EEG, Mental Performance and Well-being
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Pascoe Pharmazeutische Praeparate GmbH · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the influence of a herbal preparation containing hypericum, passionflower, and valerian on sleep structure, improvement of attention, and well-being in comparison to placebo.
Detailed description
To demonstrate the influence of the herbal combination preparation Neurapas® balance on the objective sleep structure in comparison with placebo. A further aim was to investigate whether treatment with Neurapas® balance versus placebo brings about an improvement in attention and well-being and whether these changes are related to the improvement in the sleep structure. 1. Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days vs. placebo lead to an improvement in continuity of sleep? 2. Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days vs. placebo lead to an improvement in sleep architecture, especially an increase in deep sleep? 3. Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days vs. placebo lead to an improvement in morning attentional performance? 4. Does the administration of 3 x 2 Neurapas® balance tablets over a period of three days vs. placebo lead to an improvement in morning well-being?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Neurapas® balance (Herbal product (Hypericum, Passionflower, Valerian)) | 3 x 2 tablets / day over 3 days |
| DRUG | film-coated sugar-pill | 3 x 2 tablets / day over 3 days |
Timeline
- Start date
- 2004-12-01
- Primary completion
- 2005-01-01
- Completion
- 2005-02-01
- First posted
- 2009-10-19
- Last updated
- 2010-05-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00997256. Inclusion in this directory is not an endorsement.